Aiming for Potential Breakthroughs in Cancer Care

Hightower Clinical is driving innovation in cancer research through biorepository trials that collect blood, tissue, and biomarker data to unlock new diagnostic and treatment opportunities. These non-interventional studies cover a range of cancers, including head and neck cancer, colorectal cancer, and more. By monitoring biomarker changes and exploring new cancer screening methods, we aim to improve early detection and treatment outcomes. Explore our general biorepository trials to learn more about ongoing studies and how you can participate in advancing cancer research.

Hightower Clinical’s lung biorepository trials in Oklahoma City are advancing research to improve future lung cancer treatments. These trials collect molecular and clinical data to optimize care and develop personalized strategies for lung cancer. Participants benefit from guided support, with all procedures provided at no cost. Explore our lung biorepository studies to learn more about how you can contribute to meaningful breakthroughs in lung cancer research.